Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)
Bangladesh
· Delayed Price · Currency is BDT 8.40
-0.10 (-1.18%)
At close: Apr 28, 2026
Central Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -18.92 | -21.98 | -43.96 | -43.96 | -68.25 | -8.47 | Upgrade
|
| Depreciation & Amortization | 31.33 | 21.61 | 13.45 | 26.75 | 29.76 | 32.89 | Upgrade
|
| Other Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.18 | - | - | - | Upgrade
|
| Other Operating Activities | -19.42 | -7.2 | 19.67 | 0.01 | 17.47 | 21.32 | Upgrade
|
| Change in Accounts Receivable | 4.35 | 4.35 | 7.14 | -1.3 | -0.05 | -23.03 | Upgrade
|
| Change in Inventory | -6.46 | -6.46 | 3.8 | 17.12 | 20.58 | -7.41 | Upgrade
|
| Change in Accounts Payable | 10.43 | 10.43 | 4.21 | 3.79 | 0.85 | -1.39 | Upgrade
|
| Change in Income Taxes | 0.2 | 0.2 | 4.25 | 0.18 | 0.16 | 0.89 | Upgrade
|
| Change in Other Net Operating Assets | -0.57 | -0.57 | 0.26 | 1.16 | 1.07 | -5.95 | Upgrade
|
| Operating Cash Flow | 0.03 | -0.52 | 2.97 | -0.33 | -1.12 | 1.8 | Upgrade
|
| Operating Cash Flow Growth | -98.73% | - | - | - | - | - | Upgrade
|
| Capital Expenditures | - | - | - | - | - | -6.57 | Upgrade
|
| Investing Cash Flow | - | - | - | - | - | -6.57 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 9.12 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 7.92 | 25.21 | Upgrade
|
| Total Debt Issued | - | - | - | - | 17.04 | 25.21 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | 17.04 | 25.21 | Upgrade
|
| Other Financing Activities | -0.01 | -0.01 | -0.01 | -0.01 | -17.47 | -21.45 | Upgrade
|
| Financing Cash Flow | -0.01 | -0.01 | -0.01 | -0.01 | -0.43 | 3.76 | Upgrade
|
| Net Cash Flow | -1.07 | -0.52 | 2.96 | -0.34 | -1.55 | -1.02 | Upgrade
|
| Free Cash Flow | 0.03 | -0.52 | 2.97 | -0.33 | -1.12 | -4.78 | Upgrade
|
| Free Cash Flow Growth | -98.73% | - | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 0.09% | -1.57% | 10.02% | -1.11% | -4.31% | -3.22% | Upgrade
|
| Free Cash Flow Per Share | - | -0.00 | 0.03 | -0.00 | -0.01 | -0.04 | Upgrade
|
| Cash Interest Paid | 0.01 | 0.01 | 0.01 | - | 17.36 | 21.36 | Upgrade
|
| Cash Income Tax Paid | - | -0 | 0 | 0.35 | 0.11 | 5.95 | Upgrade
|
| Levered Free Cash Flow | - | 19.07 | 4 | 17.79 | 8.19 | -19.67 | Upgrade
|
| Unlevered Free Cash Flow | - | 19.07 | 4 | 17.79 | 19.04 | -6.32 | Upgrade
|
| Change in Working Capital | 7.04 | 7.04 | 13.62 | 16.86 | 19.89 | -43.95 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.